MOMENTA PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS, INC. et al | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for MOMENTA PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS, INC. et al

Sort by

Viewing results 1‒5 of 5

LexPharmaceuticals sector
Teva/Mylan: brand management
...But unfortunately for Teva, another generic manufacturer, Momenta Pharmaceuticals, just received regulatory approval for its version of Copaxone....
April 21, 2015
Smart MoneyStephen Foley
Hedge fund stockpicking tests investors
...Funds may have sold out of Valeant, Apple et al before the rot set in....
January 4, 2016
FT Live
Future of Asset Management Europe
New fund firm models for Europe's resurgence
Tuesday, 12 NovemberLondon, UK
Smart MoneyStephen Foley
Stock pickers fail to shine in downturn
...Maybe we will discover that many managers were smart enough to sell out of Apple, Valeant, Williams et al before their shares tanked....
October 5, 2015
FT AlphavilleIzabella Kaminska
Why fintech is a marketing story
...— Recent research by Gorton et . al about the form and role of banks as maturity transformers and creators of “private money” is very relevant to this discussion....
October 5, 2015
Merryn Somerset Webb
A stellar stock? Beware the smoke trail
...Why would the Chinese, Russians, Brazilians et al make the same mistake when it is very clearly in the public domain?...
March 30, 2012

Previous pagePage 1 of 1Next page